Knowledge Mapping of COVID-19 and Asthma/Allergic Rhinitis: A Visual and Bibliometric Analysis

Journal of Asthma and Allergy, Journal Year: 2025, Volume and Issue: Volume 18, P. 705 - 721

Published: May 1, 2025

Numerous studies have highlighted a link between COVID-19 and respiratory allergic conditions such as asthma rhinitis (AR). Despite the growing volume of research, there remains notable gap in form comprehensive bibliometric analysis that consolidates findings on this association. This study aims to fill by systematically exploring how AR interact with COVID-19. By using Web Science Core Collection, we selected publications from January 2020 October 2024 related asthma/AR. Analysis tools VOSviewer CiteSpace were employed perform network mappings citation analyses, focusing co-authorship networks, keyword co-occurrences, impacts understand research dynamics collaborative patterns within field. A collection 553 was obtained, revealing an upward trend over period. The United States, China, Kingdom predominant output, demonstrating extensive international collaborations. key areas impact, influence types severity protective effects specific treatments like inhaled corticosteroids biologics. Emerging trends identified included significance socioeconomic factors obesity disease outcomes, well evolving strategies vaccination interventions. highlights significant role global interactions It points out reported safety effectiveness vaccines for these acknowledges challenges vaccine uptake among minority socioeconomically disadvantaged groups. also identifies unique risks children obese patients during pandemic underscores need increased collaboration more clinical trials, evaluate efficacy

Language: Английский

Impact of COVID-19 on adverse reactions to subcutaneous specific immunotherapy in children:a retrospective cohort study

BMC Infectious Diseases, Journal Year: 2024, Volume and Issue: 24(1)

Published: Aug. 7, 2024

COVID-19 is a new infectious disease. To investigate whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection increases the adverse reactions of subcutaneous specific immunotherapy (SCIT) in children. This study was conducted by collecting relevant data from children who underwent house dust mite SCIT April 3, 2021, to March 18, 2023, including information on time infection, symptoms, and after each allergen injection. A mixed effects model used analyze changes before infection. Among records 2658 injections 123 SCIT, overall reaction rate 39.8% 30.0% Compared with pre-infection COVID-19, risks reactions, local systemic were reduced (odds ratio [OR] = 0.24, 0.31, 0.28, all P < 0.05). incidence unvaccinated group highest (15.3% vs. 7.1%). The decreased 2-vaccinated recipients (OR 0.29–0.31, In children, SARS-CoV-2 does not increase SCIT. finding can provide basis for implementation allergen-specific (AIT) during pandemic.

Language: Английский

Desensitization reduces some COVID-19-associated symptoms in minors with allergic rhinitis

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 11, 2024

Objective The aim of this study was to observe the symptoms after infection with coronavirus disease 19 (COVID-19) in minor and adult allergic rhinitis (AR) patients receiving different treatment therapies [Sublingual immunotherapy (SLIT) conventional therapy]. Methods We recruited a total 398 diagnosed AR from clinical system divided them into AR-S, AR-S1 representing individuals aged < 18 years age, AR-S2 those ≥ AR-C groups based on their modalities. Between December 2022 February 2023, we documented respiratory common manifestations infected novel coronavirus. Results group may be associated reduced risk including dry itchy (OR = 0.373, 95%Cl:0.184–0.755), headache 0.385, 95%Cl:0.196–0.758), fatigue 0.376, 95%Cl:0.188–0.751), chest tightness 0.160, 95%Cl:0.049–0.522), some improvement (cough, fatigue). Conclusion Minor SLIT can reduce COVID-19-infected patients. Level Evidence: 3

Language: Английский